Alliança Saúde e Participações S.A.

BOVESPA:AALR3 Stock Report

Market Cap: R$1.2b

Alliança Saúde e Participações Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Alliança Saúde e Participações.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth33.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You

Apr 17
What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You

Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around

Aug 17
Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around

Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching

Jul 08
Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching

Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?

May 28
Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?

What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?

Apr 05
What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?

Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years

Mar 10
Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years

Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?

Feb 17
Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?

What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?

Jan 27
What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?

Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?

Jan 06
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?

What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?

Dec 11
What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?

Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?

Aug 07
Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?

Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Jul 20
Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?

Jul 03
Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alliança Saúde e Participações has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BOVESPA:AALR3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20231,180-22811102N/A
9/30/20231,154-263-6057N/A
6/30/20231,132-287-7750N/A
3/31/20231,100-24780206N/A
12/31/20221,085-22874187N/A
9/30/20221,092-135157261N/A
6/30/20221,110-55171270N/A
3/31/20221,127-3222124N/A
12/31/20211,137-649149N/A
9/30/20211,1603870167N/A
6/30/20211,1212958145N/A
3/31/2021978-6646116N/A
12/31/2020929-9751118N/A
9/30/2020898-10367132N/A
6/30/2020915-84120187N/A
3/31/20201,04710152228N/A
12/31/20191,07341138213N/A
9/30/20191,06950151230N/A
6/30/20191,07347111188N/A
3/31/20191,0764394177N/A
12/31/20181,0774075161N/A
9/30/20181,0741046133N/A
6/30/20181,087967157N/A
3/31/20181,082826144N/A
12/31/20171,0787-15134N/A
9/30/20171,08136N/A112N/A
6/30/20171,04226N/A101N/A
3/31/20171,01513N/A81N/A
12/31/201695115N/A79N/A
9/30/201687427N/A89N/A
6/30/2016806-3N/A97N/A
3/31/201673456N/A111N/A
12/31/2015700-13N/A99N/A
12/31/2014393-4N/A48N/A
12/31/201327628N/A17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AALR3's forecast earnings growth is above the savings rate (9.9%).

Earnings vs Market: Insufficient data to determine if AALR3's earnings are forecast to grow faster than the BR market

High Growth Earnings: Insufficient data to determine if AALR3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AALR3's revenue is forecast to grow faster than the BR market.

High Growth Revenue: Insufficient data to determine if AALR3's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AALR3's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.